News from us and our partners

Tags

Topics

0 results

News
2 September, 2026
Biotalys secures product registration in California for EVOCA®, strengthening regulatory pathway for lead asset
News
2 September, 2026
Inventiva announces last patient visit in NATiV3 Phase 3 clinical trial of Lanifibranor in MASH
News
1 September, 2026
Medtronic announces strategic investment in Pi-Cardia to accelerate innovation for complex TAVR
News
1 September, 2026
AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer
News
31 August, 2026
Inventiva appoints Chris Benecchi as Chief Operating Officer
News
20 August, 2026
Lupin and Tenpoint Therapeutics announce strategic partnership to commercialize YUVEZZI
News
20 August, 2026
Galvanize Therapeutics® announces latest exploratory evidence suggesting immune-activating potential of Aliya® PEF Energy
News
19 August, 2026
MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies
News
18 August, 2026
HotSpot Therapeutics appoints Niti Goel, M.D., as Chief Medical Officer
News
11 August, 2026
Nitrase Therapeutics announces appointment of industry veterans to Board of Directors
News
11 August, 2026
Galvanize Therapeutics® announces first commercial procedures using New Aliya® EX System
News
6 August, 2026
Mediar Therapeutics enters collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases
News
5 August, 2026
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
News
28 July, 2026
HAYA Therapeutics receives FDA Fast Track Designation for HTX-001
News
22 July, 2026
Moon Surgical and KARL STORZ announce strategic commercial collaboration to advance scalable surgery
News
21 July, 2026
MaxCyte® announces multi-platform technology license partnership with Genentech® to advance cell therapy development

Biotalys secures product registration in California for EVOCA®, strengthening regulatory pathway for lead asset

Inventiva announces last patient visit in NATiV3 Phase 3 clinical trial of Lanifibranor in MASH

Medtronic announces strategic investment in Pi-Cardia to accelerate innovation for complex TAVR

AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer

Inventiva appoints Chris Benecchi as Chief Operating Officer

Lupin and Tenpoint Therapeutics announce strategic partnership to commercialize YUVEZZI

Galvanize Therapeutics® announces latest exploratory evidence suggesting immune-activating potential of Aliya® PEF Energy

MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies

HotSpot Therapeutics appoints Niti Goel, M.D., as Chief Medical Officer

Nitrase Therapeutics announces appointment of industry veterans to Board of Directors

Galvanize Therapeutics® announces first commercial procedures using New Aliya® EX System

Mediar Therapeutics enters collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases

Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease

HAYA Therapeutics receives FDA Fast Track Designation for HTX-001

Moon Surgical and KARL STORZ announce strategic commercial collaboration to advance scalable surgery

MaxCyte® announces multi-platform technology license partnership with Genentech® to advance cell therapy development